Status:
COMPLETED
Glucose Oxidase as Treatment Against Common Cold
Lead Sponsor:
Krister Tano
Conditions:
Common Cold
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Glucose oxidase is a hydrogen peroxide producing enzyme, which also is present in honey. Human rhinoviruses are sensitive to the action of hydrogen peroxide, which is documented in laboratory studies....
Detailed Description
Persons that are convinced of that they have caught an episode of common cold can be included into the study within 24 hours after the onset of symptoms. Before they start the treatment with the nasa...
Eligibility Criteria
Inclusion
- Symptoms of a common cold within the last 24 hours
Exclusion
- Use of a nasal steroid due to allergy
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01883440
Start Date
January 1 2013
End Date
September 1 2013
Last Update
January 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Öronmottagningen
Södra Sunderbyn, Sweden